ISOPRINOSINE

Valsts: Indonēzija

Valoda: indonēziešu

Klimata pārmaiņas: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Produkta apraksts Produkta apraksts (SPC)
13-07-2022

Aktīvā sastāvdaļa:

METHISOPRINOL

Pieejams no:

DARYA-VARIA LABORATORIA TBK - Indonesia

SNN (starptautisko nepatentēto nosaukumu):

METHISOPRINOL

Deva:

500 MG

Zāļu forma:

TABLET

Vienības iepakojumā:

DUS, 1 STRIP @ 8 TABLET

Ražojis:

DARYA-VARIA LABORATORIA TBK PLANT CITEUREUP - Indonesia

Autorizācija datums:

2021-01-26

Produkta apraksts

                                1
ISOPRINOSINE®
METHISOPRINOL
TABLET
COMPOSITION
Each tablet contains
Methisoprinol ………………………………….500 mg
PRODUCT DESCRIPTION
ISOPRINOSINE® tablet appears as white-rounded tablet with imprinted
ISOPRINOSINE /NP at one
side and breakline at the other side, bitter taste, and odorless.
Methisoprinol
is
a
chemical
complex
formed
from
inosine
and
an
aminoalcohol,
dimethylaminoisopropanolol at a 1:3 ratio. It is a white powder,
slightly bitter, water soluble, and
stable in a neutral solution. This complex was discovered by Gordon,
Glasky, Lynes, and Doty,
American researchers. ISOPRINOSINE® increases protein and
nucleoprotein synthesis; preserves
the structure and function of the polyribosomes; inhibits
ribonucleases; reinforces polyribosome
function; interferes with the genetic transfer of the virus to the
polyribosome of the host cell and
in this way stops viral multiplication. From the clinical studies made
by Argentine researchers
emerges the non-specific antiviral action of wide spectrum (Ink,
Antonini, Andres, Stefano, and
others).
INDICATIONS
For the treatment of recurrent genitalia herpes and herpes labialis
occurring within 3 months.
POSOLOGY
Adults: An average of 50 mg/kg BW/day. This dosage can be increased up
to 100 mg/kg BW/day
with maximum dose is 3–4 g/day. All use in divided doses three to
four times a day, for a
maximum of 10 days.
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in the leaflet.
ISOPRINOSINE® should not be given to patients with gout and high
serum uric acid levels.
WARNINGS AND PRECAUTIONS
Since it has an evident slight cardiac effect, care should be taken
when administering to cardiac
patients under digitalis.
ISOPRINOSINE® should not be used on microbial infection diseases
since it does not have
antibacterial action.
DISETUJUI OLEH BPOM : 23 JUNI 2022
EREG10008712000050
2
Methisoprinol may cause a transient elevation of baseline serum and
urinary uric acid, usually
remaining within the normal range (using 8
                                
                                Izlasiet visu dokumentu
                                
                            

Meklēt brīdinājumus, kas saistīti ar šo produktu

Skatīt dokumentu vēsturi